INO
Inovio Pharmaceuticals Inc
1.20$
-0.9%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -73.6% | -100.0% | – | -100.0% | – | -44.1% | -100.0% | – | – | – | – | – | |
| – | -83.0% | +333.6% | +9.1% | -7.6% | +1.3% | – | – | +1.1% | +0.6% | -1.1% | – | – | |
| – | -118.7% | – | – | – | – | – | -1,235.0% | – | – | – | – | – | |
| – | +11.3% | +21.2% | +10.4% | -18.9% | -31.2% | +124,776.5% | -99.9% | -5.9% | -23.0% | +34.0% | -21.3% | – | |
| – | +3.2% | +3.2% | +96,452.0% | -15.6% | -99.9% | +118,632.3% | -5.1% | -99.9% | -8.4% | +109,109.8% | -99.9% | – | |
| – | -24.0% | +15.2% | +3.1% | -15.8% | -27.9% | +127,322.4% | -99.9% | -5.1% | -21.2% | +26.8% | -12.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -9.9% | -37.0% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -622.8% | – | – | |
| – | – | +23,881,700.0% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -622.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | -519.1% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.